Inactive Instrument

Qualis Innovations, Inc. Stock Other OTC

Equities

QLIS

US74754Q1058

Phones & Handheld Devices

Sales 2022 - Sales 2023 - Capitalization 2.54M
Net income 2022 - Net income 2023 - EV / Sales 2022 -
Net cash position 2022 38.67K Net Debt 2023 6.67K EV / Sales 2023 -
P/E ratio 2022
-7.39 x
P/E ratio 2023
-3.16 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 43.36%
More Fundamentals * Assessed data
Dynamic Chart
Qualis Innovations, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Qualis Innovations, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Qualis Innovations, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Qualis Innovations, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Qualis Innovations, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Qualis Innovations, Inc. Auditor Raises 'Going Concern' Doubt CI
Qualis Innovations, Inc. Announces Resignation of Dr. Robert Bilkovski as Chief Scientific Officer CI
Qualis Innovations, Inc. Announces Resignation of Joseph V. Pergolizzi Jr. as Acting Chief Executive Officer CI
Qualis Innovations, Inc. Announces Resignation of Joseph V. Pergolizzi Jr. as Member of, and Chairman of, the Board of Directors CI
Qualis Innovations, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Qualis Innovations, Inc. announced that it expects to receive $4 million in funding CI
Qualis Innovations, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Qualis Innovations, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Qualis Innovations, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Qualis Innovations, Inc. Auditor Raises 'Going Concern' Doubt CI
More news
Managers TitleAgeSince
Chief Tech/Sci/R&D Officer 47 -
Members of the board TitleAgeSince
Director/Board Member 78 07-12-02
More insiders
Qualis Innovations, Inc. is the holding company under which mPathix Health, Inc. (mPathix) operates. mPathix is a clinical-stage company focused on the development, production and distribution of pain management and other central nervous system-based solutions. It develops products designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their treatment regimen. Its product, which is its sole product and is in the development pipeline, is SOLACE, a non-invasive medical device that uses electromagnetic induction to generate deep heat below the surface of the skin to reduce and relieve pain. SOLACE delivers radio frequency (RF) energy continuously and thereby delivers thermal effects to the tissues and utilizes several differentiated features vs other RF devices on the market. SOLACE device is based on high-frequency magnetic induction technology, which it refers to as Electromagnetic Induction.
More about the company